Subscribe To
Moore kuehn encourages vblt, radi, tcrr, and bte investors to contact law firm
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New Y...
March 7, 2023, 3:40 pm
Moore kuehn encourages ptrs, vblt, indt, and jnce investors to contact law firm
NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New Yo...
February 28, 2023, 2:28 am
Lifshitz law pllc announces investigations of vblt, hrzn, infi, and meip
NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) — Vascular Biogenics Ltd. (NASDAQ: vblt) Lifshitz Law PLLC a...
February 26, 2023, 1:11 am
Why is vascular biogenics (vblt) stock up 52%?
Vascular Biogenics (NASDAQ: vblt ) stock is rocketing higher on Thursday following news of a merger wit...
February 23, 2023, 11:03 am
Why vascular biogenics stock is plunging
Vascular Biogenics Ltd (NASDAQ: vblt) shares are falling Wednesday after the company announced that th...
July 20, 2022, 9:44 am
Vascular biogenics (vblt) reports q1 loss, misses revenue estimates
Vascular Biogenics (vblt) delivered earnings and revenue surprises of -8.33% and 42.35%, respectively, ...
May 17, 2022, 9:47 am
Vascular biogenics ltd. (vblt) ceo dror harats on q4 2021 results - earnings call transcript
Vascular Biogenics Ltd. (vblt) CEO Dror Harats on Q4 2021 Results - Earnings Call Transcript...
March 23, 2022, 1:45 pm
Update -- vbl therapeutics to report year-end 2021 financial results on march 23
TEL AVIV, Israel and NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: vblt), a la...
March 14, 2022, 9:57 am
What makes vascular biogenics (vblt) a new buy stock
Vascular Biogenics (vblt) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
November 18, 2021, 1:45 pm
What makes vascular biogenics (vblt) a new buy stock
Vascular Biogenics (vblt) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
November 18, 2021, 1:45 pm
What makes vascular biogenics (vblt) a new buy stock
Vascular Biogenics (vblt) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about...
November 18, 2021, 1:45 pm